欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Polo-like Kinase (PLK)-TAK-960
TAK-960

Chemical Structure : TAK-960

CAS No.: 1137868-52-0

TAK-960 (TAK960)

货号: PC-25813Not For Human Use, Lab Use Only.

TAK-960 is a potent, selective, ATP-competitive, orally available inhibitor of polo-like kinase 1 (PLK1) with IC50 of 1.6 nM in TR-FRET assays.

规格 价格 库存 数量
5 mg ¥980 In stock
10 mg ¥1480 In stock
25 mg ¥2580 In stock
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

TAK-960 is a potent, selective, ATP-competitive, orally available inhibitor of polo-like kinase 1 (PLK1) with IC50 of 1.6 nM in TR-FRET assays.
TAK-960 inhibits full-length PLK1 protein with IC50 of 0.8 nM, relatively inhibits PLK2 and PLK3 with IC50 of 16.9 and 50.2 nM, weakly inhibits FAK, MLCK, and FES kinases against a panel of 288 kinases.
TAK-960 (10-30 nM) induces accumulation of aberrant mitotic cells in HT-29 cells.
TAK-960 inhibits proliferation of human cancer cell lines regardless of TP53 and KRAS mutation and MDR1 expression status.
TAK-960 treatment caused accumulation of G2–M cells, aberrant polo mitosis morphology, and increased phosphorylation of histone H3 (pHH3) in vitro and in vivo.
TAK-960 inhibits proliferation of multiple cancer cell lines, with mean EC50 values ranging from 8.4 to 46.9 nM, but not in nondividing normal cells.
TAK-960 significantly inhibited the growth of HT-29 colorectal cancer xenografts, exhibited significant efficacy against multiple tumor xenografts, including an adriamycin/paclitaxel-resistant xenograft model and a disseminated leukemia model.

物理化学性质&存储条件

分子量 561.61
分子式 C27H34F3N7O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide

参考文献

1. Hikichi Y, et al. Mol Cancer Ther. 2012 Mar;11(3):700-9.

2. Nie Z, et al. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3662-6.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: